Research suggests flexible approach to antiplatelet management after coronary drug-eluting ...

In patients with coronary drug-eluting stents undergoing non-cardiac surgery, aspirin monotherapy showed no difference in ischemic outcomes or major bleeding compared to no antiplatelet therapy. The ASSURE DES trial, involving 926 patients, found similar rates of primary outcomes and major bleeding, with a slight increase in minor bleeding in the aspirin group. The low event rate suggests a need for further research in higher-risk scenarios.